TLN-121

· Treeline Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TLN-121, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas [Phase 1]